Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
Martina Schneider(Valneva (Austria)), Nina Wressnigg(Valneva (Austria)), Romana Hochreiter(Valneva (Austria)), Robert P. McMahon(Valneva (Austria)), Susanne Eder-Lingelbach(Valneva (Austria)), Karin Kosulin(Valneva (Austria)), Sebastian Toepfer(Valneva (Austria)), Ulrike Fuchs(Valneva (Austria)), Robert M. Mader(Valneva (Austria)), Vera Buerger(Valneva (Austria)), Julian Larcher‐Senn, Katrin Dubischar(Valneva (Austria)), Marivic Narciso-Abraham(Valneva (Austria)), Sandra Hadl(Valneva (Austria)), Annegret Bitzer(Valneva (Austria)), Juan-Carlos Jaramillo(Valneva (Austria)), Oliver Zoihsl(Valneva (Austria))
Cited by 218
Related Papers
Drosophila Stardust is a partner of Crumbs in the control of epithelial cell polarity
|Nature|2001|273
Scavenger Receptor Class B Type I (SR-BI) Is Involved in Vitamin E Transport across the Enterocyte
|Journal of Biological Chemistry|2005|241
A Tissue Adhesion‐Controllable and Biocompatible Small‐Scale Hydrogel Adhesive Robot
|Advanced Materials|2022|188
Cloning and identification of an oxytocin/vasopressin-like receptor and its ligand from insects
|Proceedings of the National Academy of Sciences|2008|186